D.E. Shaw & Co’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

D.E. Shaw & Co’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$953K	–	4173
2019 Q2	$953K	Hold	10,000	–	–	﹤0.01%	2697
2019 Q1	$913K	Buy	+10,000	New	+$818K	﹤0.01%	2657
2016 Q4	–	Sell	-10,000	Closed	-$1.25M	–	3725
2016 Q3	$1.25M	Sell	10,000 -10,900	-52%	-$1.29M	﹤0.01%	2256
2016 Q2	$2.22M	Buy	20,900 +10,000	+92%	+$1.16M	﹤0.01%	1861
2016 Q1	$1.25M	Sell	10,900 -4,500	-29%	-$528K	﹤0.01%	2212
2015 Q4	$2.19M	Buy	15,400 +900	+6%	+$104K	﹤0.01%	2059
2015 Q3	$1.3M	Buy	14,500 +4,500	+45%	+$475K	﹤0.01%	2416
2015 Q2	$1.15M	Buy	+10,000	New	+$1.05M	﹤0.01%	2593

D.E. Shaw & Co's CBPO Position: Q2 2021 in Review

D.E. Shaw & Co sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 21,714 shares — an estimated $2.57M sold.

D.E. Shaw & Co first reported a position in CBPO in Q2 2014 and held it in 28 quarters. The position peaked at $17.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

D.E. Shaw & Co reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
D.E. Shaw & Co sold 21,714 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $2.57M.
D.E. Shaw & Co first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 28 quarters.
D.E. Shaw & Co's China Biologic Products Holdings, Inc. position peaked at $17.8M in Q2 2018.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.